Using the CLSA to address vaccine-related research questions - hosted by the CVPD

Поділитися
Вставка
  • Опубліковано 26 чер 2023
  • This webinar was hosted by the Centre for Vaccine Preventable Diseases (CVPD) on June 19, 2023.
    The National Advisory Committee on Immunization (NACI) strongly recommends that, among other high-risk groups, adults aged 65 years and older be vaccinated against influenza and pneumococcal disease. Yet, vaccination coverage rates remain low.
    The Canadian Longitudinal Study on Aging (CLSA) offers a unique opportunity to investigate the relationship between vaccine uptake and a wide range of sociodemographic, clinical, and behavioural factors among Canadian adults - particularly among older age groups. In this webinar, Dr. Giorgia Sulis shares her insights on the use of CLSA data to identify vaccine coverage gaps in older adults and inform policies that improve vaccine uptake in this demographic.
    Dr. Giorgia Sulis
    Assistant Professor, University of Ottawa
    Dr. Giorgia Sulis is an Assistant Professor in the School of Epidemiology and Public Health at the University of Ottawa, an Associate Scientist in the Clinical Epidemiology Program of the Ottawa Hospital Research Institute (OHRI), and a member of the McGill International Tuberculosis Centre. Dr. Sulis' research interests span infectious disease epidemiology, ranging from prescribing practices, particularly in resource-limited settings and with an emphasis on the primary level of care, to best research practices, including the optimization of knowledge synthesis methods. By integrating a range of methodological approaches, Dr. Sulis seeks to generate new and timely evidence that will inform decision-making and help shape clinical and public health practice changes.
    About the Centre for Vaccine Preventable Diseases (CVPD):
    With leadership housed at the University of Toronto’s Dalla Lana School of Public Health, we are developing an interdisciplinary group of academic researchers, educators and public health advocates. Our vision is to catalyze cutting-edge research and education that maximizes the health benefits of immunization for everyone.

КОМЕНТАРІ •